Insider Trading activities of Momenta Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Momenta Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Momenta Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Momenta Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is MNTA. The reporting company's CIK number is 1235010.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $78,746,710.
The total value of stock option exercises since 2005 is $12,303,992.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Momenta Pharmaceuticals Inc (MNTA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-04 0 $0 75,432 $1,481,383 63,823 $735,550
2018-03 0 $0 3,399 $64,581 5,000 $44,250
2018-02 0 $0 52,149 $826,556 44,246 $74,863
2018-01 0 $0 51,930 $795,820 44,866 $447,465
2017-12 0 $0 5,500 $72,050 0 $0
2017-11 0 $0 8,339 $110,604 0 $0
2017-09 0 $0 50,284 $927,053 39,834 $295,169
2017-08 0 $0 29,379 $485,260 11,500 $85,215
2017-05 0 $0 8,379 $131,824 0 $0
2017-02 0 $0 7,745 $120,315 0 $0
2017-01 0 $0 5,000 $90,000 39,647 $400,831
2016-12 0 $0 11,250 $168,750 0 $0
2016-11 0 $0 10,020 $136,995 0 $0
2016-08 0 $0 10,022 $120,624 0 $0
2016-06 0 $0 5,200 $67,600 5,200 $67,080
2016-05 0 $0 10,779 $109,954 0 $0
2016-04 0 $0 2,843 $27,207 0 $0
2016-02 0 $0 46,175 $282,126 0 $0
2015-12 0 $0 520 $8,236 0 $0
2015-11 0 $0 62,972 $1,132,339 41,667 $674,172
2015-09 0 $0 513 $9,705 0 $0
2015-08 0 $0 47,054 $1,041,049 20,000 $344,600
2015-07 0 $0 4,570 $102,139 6,667 $52,135
2015-06 0 $0 426,432 $9,865,529 364,920 $5,303,773
2015-05 0 $0 83,050 $1,679,725 72,025 $944,107
2015-04 0 $0 194,846 $3,797,208 131,667 $1,649,472
2015-03 0 $0 46,969 $704,358 0 $0
2015-02 0 $0 25,184 $330,296 10,000 $88,500
2015-01 0 $0 0 $0 11,250 $77,400
2014-12 0 $0 17,750 $214,695 25,000 $172,000
2014-11 0 $0 11,267 $127,211 0 $0
2014-10 0 $0 3,723 $44,676 5,000 $44,250
2014-09 0 $0 3,640 $41,568 0 $0
2014-08 0 $0 16,810 $197,696 0 $0
2014-05 0 $0 9,105 $107,168 0 $0
2014-04 0 $0 485 $5,218 0 $0
2014-03 0 $0 64 $922 31,200 $153,192
2014-02 0 $0 53,764 $960,447 12,800 $62,848
2014-01 0 $0 27,159 $529,600 0 $0
2013-11 0 $0 56,017 $997,222 0 $0
2013-10 0 $0 5,247 $81,118 0 $0
2013-08 0 $0 9,432 $140,663 0 $0
2013-07 0 $0 30,000 $498,300 0 $0
2013-06 0 $0 32,072 $468,571 0 $0
2013-05 0 $0 9,107 $118,854 0 $0
2013-03 0 $0 31,440 $444,570 0 $0
2013-02 0 $0 20,058 $247,976 0 $0
2012-12 0 $0 0 $0 7,200 $7,128
2012-11 0 $0 9,292 $99,303 0 $0
2012-10 0 $0 1,000 $14,530 0 $0
2012-08 0 $0 20,675 $286,224 0 $0
2012-07 0 $0 1,600 $22,592 0 $0
2012-06 0 $0 1,420 $20,216 46,728 $28,504
2012-05 0 $0 11,790 $164,655 0 $0
2012-04 0 $0 17,000 $257,280 0 $0
2012-03 0 $0 2,000 $30,060 0 $0
2012-02 0 $0 23,946 $367,917 0 $0
2012-01 0 $0 2,000 $38,780 0 $0
2011-12 0 $0 2,426 $37,601 3,000 $42,270
2011-11 0 $0 14,016 $208,254 0 $0
2011-10 0 $0 2,000 $24,660 0 $0
2011-09 0 $0 3,746 $61,963 0 $0
2011-08 0 $0 13,125 $210,321 0 $0
2011-07 0 $0 28,787 $587,534 0 $0
2011-06 0 $0 26,629 $536,069 0 $0
2011-05 0 $0 33,827 $649,165 0 $0
2011-04 0 $0 9,034 $163,241 0 $0
2011-03 0 $0 6,493 $92,272 0 $0
2011-02 0 $0 27,696 $372,128 7,000 $86,380
2010-12 0 $0 127,350 $1,847,704 64,000 $14,784
2010-11 0 $0 9,118 $139,199 0 $0
2010-10 0 $0 0 $0 55,730 $12,873
2010-09 0 $0 15,852 $238,894 0 $0
2010-08 0 $0 218,752 $4,085,767 0 $0
2010-07 0 $0 202,950 $4,400,886 0 $0
2010-06 0 $0 3,353 $49,007 0 $0
2010-05 0 $0 13,639 $169,453 0 $0
2010-04 0 $0 0 $0 35,200 $103,840
2010-03 0 $0 77,598 $1,163,102 32,000 $7,392
2010-02 0 $0 15,388 $229,155 0 $0
2010-01 0 $0 42,483 $637,145 0 $0
2009-12 0 $0 677 $7,528 0 $0
2009-11 0 $0 4,668 $50,250 0 $0
2009-09 0 $0 673 $6,987 0 $0
2009-08 0 $0 5,100 $50,361 0 $0
2009-06 0 $0 677 $6,157 0 $0
2009-05 0 $0 3,096 $26,460 0 $0
2009-03 0 $0 633 $5,527 0 $0
2009-02 0 $0 11,655 $124,328 0 $0
2009-01 0 $0 9,495 $113,940 0 $0
2008-12 0 $0 12,380 $146,060 0 $0
2008-11 0 $0 371 $2,882 0 $0
2008-08 0 $0 48,540 $849,716 0 $0
2008-06 0 $0 335 $4,440 0 $0
2008-04 0 $0 9,375 $121,875 0 $0
2008-03 0 $0 375 $3,449 0 $0
2007-12 0 $0 1,500 $10,770 0 $0
2007-10 0 $0 10,000 $125,972 0 $0
2007-09 0 $0 10,000 $111,750 0 $0
2007-08 0 $0 10,000 $105,050 0 $0
2007-07 0 $0 10,000 $104,400 0 $0
2007-06 0 $0 10,000 $121,250 0 $0
2007-05 0 $0 10,000 $120,660 0 $0
2007-04 0 $0 16,666 $246,290 0 $0
2007-03 0 $0 10,000 $123,370 0 $0
2007-02 0 $0 21,250 $376,800 11,250 $94,612
2007-01 0 $0 93,666 $1,587,741 0 $0
2006-12 0 $0 136,166 $2,299,821 0 $0
2006-11 0 $0 142,166 $2,276,913 0 $0
2006-10 0 $0 86,254 $1,287,385 0 $0
2006-09 0 $0 258,976 $3,931,187 0 $0
2006-08 0 $0 370,088 $6,015,083 0 $0
2006-07 0 $0 21,500 $274,560 1,500 $12,150
2006-06 0 $0 10,000 $139,400 0 $0
2006-05 0 $0 45,821 $706,544 0 $0
2006-04 0 $0 165,700 $2,811,520 0 $0
2006-03 0 $0 3,383 $82,545 0 $0
2006-02 0 $0 81,706 $2,000,715 21,875 $177,187
2005-12 0 $0 22,000 $536,926 0 $0
2005-11 0 $0 22,000 $463,900 0 $0
2005-10 0 $0 22,000 $590,448 0 $0
2005-09 0 $0 22,200 $596,728 0 $0
2005-08 0 $0 22,000 $509,780 0 $0
2005-07 0 $0 22,000 $491,596 0 $0
2005-06 0 $0 89,500 $1,213,204 0 $0
2005-05 0 $0 90,500 $843,604 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Momenta Pharmaceuticals Inc insiders (MNTA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-04-19 Kwon Young (SVP, Corporate Development) Sale 15,089 20.90 315,360
2018-04-19 Kwon Young (SVP, Corporate Development) Option Ex 14,589 14.45 210,840
2018-04-19 Wheeler Craig A (President & CEO) Sale 5,896 21.00 123,816
2018-04-19 Wheeler Craig A (President & CEO) Option Ex 900 10.43 9,387
2018-04-12 Stoner Elizabeth Sale 7,714 20.00 154,280
2018-04-12 Stoner Elizabeth Option Ex 10,000 12.34 123,400
2018-04-10 Stoner Elizabeth Sale 3,399 19.00 64,581
2018-04-10 Stoner Elizabeth Option Ex 5,000 8.85 44,250
2018-04-10 Wheeler Craig A (President & CEO) Sale 43,334 19.00 823,346
2018-04-10 Wheeler Craig A (President & CEO) Option Ex 33,334 10.43 347,673
2018-03-21 Stoner Elizabeth Sale 3,399 19.00 64,581
2018-03-21 Stoner Elizabeth Option Ex 5,000 8.85 44,250
2018-02-21 Leicher Bruce (SVP & General Counsel) Sale 728 15.90 11,575
2018-02-21 Kaundinya Ganesh Venkataraman (COO & CSO) Sale 745 15.90 11,845
2018-02-21 Wheeler Craig A (President & CEO) Sale 3,938 16.45 64,799
2018-02-14 Storer Scott M (SVP, CFO) Sale 3,972 15.16 60,215
2018-02-14 Leicher Bruce (SVP & General Counsel) Sale 4,639 15.16 70,327
2018-02-14 Kaundinya Ganesh Venkataraman (COO & CSO) Sale 4,645 15.16 70,418
2018-02-14 Wheeler Craig A (President & CEO) Sale 16,875 16.14 272,362
2018-02-12 Leicher Bruce (SVP & General Counsel) Sale 309 16.20 5,005
2018-02-12 Kaundinya Ganesh Venkataraman (COO & CSO) Sale 341 16.20 5,524
2018-02-12 Kaundinya Ganesh Venkataraman (COO & CSO) Option Ex 10,103 7.41 74,863
2018-02-12 Wheeler Craig A (President & CEO) Sale 1,773 16.18 28,687
2018-02-08 Leicher Bruce (SVP & General Counsel) Sale 1,861 16.00 29,776
2018-02-08 Leicher Bruce (SVP & General Counsel) Option Ex 5,381 .00 0
2018-02-08 Kaundinya Ganesh Venkataraman (COO & CSO) Sale 1,917 16.00 30,672
2018-02-08 Kaundinya Ganesh Venkataraman (COO & CSO) Option Ex 5,637 .00 0
2018-02-08 Wheeler Craig A (President & CEO) Sale 10,406 15.89 165,351
2018-02-08 Wheeler Craig A (President & CEO) Option Ex 23,125 .00 0
2018-01-30 Stoner Elizabeth Sale 16,264 18.00 292,752
2018-01-30 Stoner Elizabeth Option Ex 19,200 13.40 257,280
2018-01-02 Wheeler Craig A (President & CEO) Sale 35,666 14.11 503,068
2018-01-02 Wheeler Craig A (President & CEO) Option Ex 25,666 7.41 190,185
2017-12-13 Stoner Elizabeth Sale 5,500 13.10 72,050
2017-11-21 Leicher Bruce (SVP & General Counsel) Sale 803 13.15 10,559
2017-11-21 Kaundinya Ganesh Venkataraman (COO & CSO) Sale 821 13.15 10,796
2017-11-21 Wheeler Craig A (President & CEO) Sale 4,116 13.35 54,928
2017-11-10 Leicher Bruce (SVP & General Counsel) Sale 355 13.07 4,639
2017-11-10 Kaundinya Ganesh Venkataraman (COO & CSO) Sale 392 13.12 5,143
2017-11-10 Wheeler Craig A (President & CEO) Sale 1,852 13.25 24,539
2017-09-28 Wheeler Craig A (President) Sale 35,667 19.02 678,564
2017-09-28 Wheeler Craig A (President) Option Ex 25,667 7.41 190,192
2017-09-01 Wheeler Craig A (President) Sale 14,617 17.00 248,489
2017-09-01 Wheeler Craig A (President) Option Ex 14,167 7.41 104,977
2017-08-31 Wheeler Craig A (President) Sale 5,750 17.00 97,750
2017-08-31 Wheeler Craig A (President) Option Ex 2,300 7.41 17,043
2017-08-21 Leicher Bruce (SVP & General Counsel) Sale 802 15.20 12,190
2017-08-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 821 15.20 12,479
2017-08-21 Wheeler Craig A (President) Sale 4,116 15.06 62,007
2017-08-10 Leicher Bruce (SVP & General Counsel) Sale 350 16.60 5,810
2017-08-10 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 387 16.60 6,424
2017-08-10 Wheeler Craig A (President) Sale 16,953 16.82 285,200
2017-08-10 Wheeler Craig A (President) Option Ex 9,100 7.41 67,431
2017-08-02 Wheeler Craig A (President) Sale 200 17.00 3,400
2017-08-02 Wheeler Craig A (President) Option Ex 100 7.41 741
2017-05-22 Leicher Bruce (SVP & General Counsel) Sale 859 14.80 12,713
2017-05-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 821 15.90 13,053
2017-05-19 Wheeler Craig A (President) Sale 4,116 15.83 65,156
2017-05-10 Leicher Bruce (SVP & General Counsel) Sale 347 16.00 5,552
2017-05-10 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 384 16.00 6,144
2017-05-10 Wheeler Craig A (President) Sale 1,852 15.77 29,206
2017-02-22 Leicher Bruce (SVP & General Counsel) Sale 1,050 15.60 16,380
2017-02-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 1,069 15.60 16,676
2017-02-22 Wheeler Craig A (President) Sale 5,626 15.51 87,259
2017-01-31 Leicher Bruce (SVP & General Counsel) Sale 5,000 18.00 90,000
2017-01-09 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Option Ex 39,647 10.11 400,831
2016-12-15 Shea Richard P (SVP, CFO) Sale 9,799 15.00 146,985
2016-12-09 Shea Richard P (SVP, CFO) Sale 1,451 15.00 21,765
2016-11-22 Roach James M. (Senior VP, Development and Chi) Sale 250 14.40 3,600
2016-11-22 Leicher Bruce (SVP & General Counsel) Sale 227 14.40 3,268
2016-11-22 Shea Richard P (SVP, CFO) Sale 227 14.40 3,268
2016-11-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 14.40 3,268
2016-11-22 Wheeler Craig A (President) Sale 1,764 14.05 24,784
2016-11-21 Roach James M. (Senior VP, Development and Chi) Sale 841 13.45 11,311
2016-11-21 Leicher Bruce (SVP & General Counsel) Sale 803 13.45 10,800
2016-11-21 Shea Richard P (SVP, CFO) Sale 744 13.45 10,006
2016-11-21 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 821 13.45 11,042
2016-11-21 Wheeler Craig A (President) Sale 4,116 13.52 55,648
2016-08-22 Roach James M. (Senior VP, Development and Chi) Sale 249 12.10 3,012
2016-08-22 Leicher Bruce (SVP & General Counsel) Sale 227 12.10 2,746
2016-08-22 Shea Richard P (SVP, CFO) Sale 227 12.10 2,746
2016-08-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 12.10 2,746
2016-08-22 Wheeler Craig A (President) Sale 1,764 12.00 21,168
2016-08-19 Roach James M. (Senior VP, Development and Chi) Sale 842 12.04 10,137
2016-08-19 Leicher Bruce (SVP & General Counsel) Sale 803 12.04 9,668
2016-08-19 Shea Richard P (SVP, CFO) Sale 745 12.04 8,969
2016-08-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 822 12.04 9,896
2016-08-19 Wheeler Craig A (President) Sale 4,116 12.04 49,536
2016-06-01 Shapiro Bennett M Sale 5,200 13.00 67,600
2016-06-01 Shapiro Bennett M Option Ex 5,200 12.90 67,080
2016-05-20 Roach James M. (Senior VP, Development and Chi) Sale 250 10.11 2,527
2016-05-20 Leicher Bruce (SVP & General Counsel) Sale 1,000 10.40 10,400
2016-05-20 Shea Richard P (SVP, CFO) Sale 227 10.11 2,294
2016-05-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 10.11 2,294
2016-05-20 Wheeler Craig A (President) Sale 1,764 10.13 17,869
2016-05-19 Roach James M. (Senior VP, Development and Chi) Sale 842 10.20 8,588
2016-05-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 784 10.20 7,996
2016-05-19 Shea Richard P (SVP, CFO) Sale 746 10.20 7,609
2016-05-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 823 10.20 8,394
2016-05-19 Wheeler Craig A (President) Sale 4,116 10.20 41,983
2016-04-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,843 9.57 27,207
2016-02-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 102 9.80 999
2016-02-22 Roach James M. (Senior VP, Development and Chi) Sale 250 9.65 2,412
2016-02-22 Leicher Bruce (SVP & General Counsel) Sale 227 9.65 2,190
2016-02-22 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 1,095 9.68 10,618
2016-02-22 Shea Richard P (SVP, CFO) Sale 227 9.65 2,190
2016-02-22 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 9.65 2,190
2016-02-22 Wheeler Craig A (President) Sale 1,688 9.95 16,795
2016-02-19 Roach James M. (Senior VP, Development and Chi) Sale 2,158 9.64 20,813
2016-02-19 Leicher Bruce (SVP & General Counsel) Sale 2,000 9.64 19,290
2016-02-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 2,065 9.63 19,913
2016-02-19 Shea Richard P (SVP, CFO) Sale 1,823 9.64 17,582
2016-02-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 2,138 9.64 20,621
2016-02-19 Wheeler Craig A (President) Sale 9,844 9.36 92,139
2016-02-18 Roach James M. (Senior VP, Development and Chi) Sale 272 10.49 2,853
2016-02-18 Leicher Bruce (SVP & General Counsel) Sale 337 10.49 3,535
2016-02-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 272 10.49 2,853
2016-02-18 Shea Richard P (SVP, CFO) Sale 183 10.49 1,919
2016-02-18 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 272 10.49 2,853
2016-02-17 Wheeler Craig A (President) Sale 1,688 11.30 19,074
2016-02-09 Roach James M. (Senior VP, Development and Chi) Sale 17,100 .00 0
2015-12-11 Franken Michael (President, Biosimilars Busines) Sale 520 15.84 8,236
2015-11-23 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 80 17.91 1,432
2015-11-20 Roach James M. (Senior VP, Development and Chi) Sale 360 17.75 6,390
2015-11-20 Leicher Bruce (SVP & General Counsel) Sale 328 17.75 5,822
2015-11-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 468 17.75 8,307
2015-11-20 Shea Richard P (SVP, CFO) Sale 227 17.75 4,029
2015-11-20 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 227 17.75 4,029
2015-11-20 Wheeler Craig A (President) Sale 1,766 17.86 31,540
2015-11-19 Roach James M. (Senior VP, Development and Chi) Sale 603 18.17 10,956
2015-11-19 Leicher Bruce (SVP & General Counsel) Sale 603 18.17 10,956
2015-11-19 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 574 18.17 10,429
2015-11-19 Shea Richard P (SVP, CFO) Sale 397 18.17 7,213
2015-11-19 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 397 18.17 7,213
2015-11-19 Wheeler Craig A (President) Sale 2,061 18.05 37,201
2015-11-18 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 76 17.70 1,345
2015-11-17 Roach James M. (Senior VP, Development and Chi) Sale 312 17.65 5,506
2015-11-17 Leicher Bruce (SVP & General Counsel) Sale 387 17.65 6,830
2015-11-17 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 312 17.65 5,506
2015-11-17 Shea Richard P (SVP, CFO) Sale 145 17.65 2,559
2015-11-17 Kaundinya Ganesh Venkataraman (Senior V.P., Research) Sale 216 17.65 3,812
2015-11-17 Wheeler Craig A (President) Sale 1,766 17.70 31,258
2015-11-05 Wheeler Craig A (President) Sale 51,667 18.00 930,006
2015-11-05 Wheeler Craig A (President) Option Ex 41,667 16.18 674,172
2015-09-11 Franken Michael (President, Biosimilars Busines) Sale 513 18.92 9,705
2015-08-21 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 79 20.01 1,580
2015-08-20 Roach James M. (Senior VP, Development and Chi) Sale 363 22.20 8,058
2015-08-20 Leicher Bruce (SVP & General Counsel) Sale 330 22.20 7,326
2015-08-20 Bishop John E (Senior VP, Pharmaceutical Scie) Sale 470 22.20 10,434
2015-08-20 Shea Richard P (SVP, CFO) Sale 228 22.20 5,061

Insider trading activities including stock purchases, stock sales, and option exercises of MNTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Momenta Pharmaceuticals Inc (symbol MNTA, CIK number 1235010) see the Securities and Exchange Commission (SEC) website.